Referred to the House Committee on Energy and Commerce.
This bill reauthorizes and amends the PREEMIE program, extending its covered fiscal years from 2019–2023 to 2025–2029 and making a technical correction to prior legislation. It requires the Secretary of HHS to establish an interagency working group within 18 months and directs HHS to contract with the National Academies to convene a committee within 30 days to study preterm births.
Privacy vs. transparency over required raw data release
Narrow, noncontroversial public‑health reauthorization with clear deliverables; typically attracts bipartisan support in the House.
This bill reauthorizes and amends the PREEMIE program, extending its covered fiscal years from 2019–2023 to 2025–2029 and making a technical correction to prior legislation.
It requires the Secretary of HHS to establish an interagency working group within 18 months and directs HHS to contract with the National Academies to convene a committee within 30 days to study preterm births.
The National Academies must produce a consensus report within 24 months including assessments of costs, risk factors, detection opportunities, and analyses of research strategies, state best practices, and precision/preventative approaches, and must include the raw data used.
Technocratic health reauthorization with specific study requirements is typically low‑controversy and often enacted, subject to appropriation and floor scheduling.
How solid the drafting looks.
Privacy vs. transparency over required raw data release
These are examples from the analysis, not a ranked list of the most-affected groups.
Privacy vs. transparency over required raw data release
Generally supportive: the bill strengthens federal attention to preterm birth research, coordination, and data-driven prevention.
It aligns with priorities on maternal and child health, equity, and funding for evidence-based interventions.
Cautiously supportive: the bill promotes evidence-gathering and federal coordination on a non-controversial health issue, but raises practical questions about costs, timelines, and implementation.
Would favor clarifying resources and privacy protections.
Mildly supportive but cautious: improving maternal and infant outcomes and reducing NICU costs are desirable, but concerns exist about added federal mandates, data sharing, and federal overreach into state health programs.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic health reauthorization with specific study requirements is typically low‑controversy and often enacted, subject to appropriation and floor scheduling.
The bill has not accumulated any surfaced votes yet.
Privacy vs. transparency over required raw data release
Technocratic health reauthorization with specific study requirements is typically low‑controversy and often enacted, subject to appropriati…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for PREEMIE Reauthorization Act of 2025.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.